Lantheus Holdings (LNTH) Tax Provisions (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Tax Provisions of $38.0 million for Q1 2026, up 61.08% year-over-year from $23.6 million in Q1 2025, and up 158.19% quarter-over-quarter from -$65.3 million in Q4 2025.
Lantheus Holdings (LNTH) Tax Provisions (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Tax Provisions for 13 consecutive years, with $38.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Tax Provisions rose 61.08% year-over-year to $38.0 million; the TTM figure through Mar 2026 stood at $13.1 million (up 156.17% YoY), while the FY2025 annual figure was -$1.3 million, down 106.09% from the prior year.
- Tax Provisions grew to $38.0 million in Q1 2026 per LNTH's latest filing, from -$65.3 million in the prior quarter.
- Across five years, Tax Provisions topped out at $45.0 million in Q3 2024 and bottomed at -$85.8 million in Q4 2024.
- Historically, Tax Provisions has averaged $8.4 million across 5 years, with a median of $22.3 million in 2024.
- On a YoY basis, Tax Provisions climbed as much as 1110.48% in 2022 and fell as far as 7104.29% in 2022.
- Lantheus Holdings' Tax Provisions stood at -$57.1 million in 2022, then jumped by 164.91% to $37.0 million in 2023, then tumbled by 331.66% to -$85.8 million in 2024, then increased by 23.92% to -$65.3 million in 2025, then jumped by 158.19% to $38.0 million in 2026.
- Business Quant data shows LNTH's Tax Provisions at $38.0 million in Q1 2026, -$65.3 million in Q4 2025, and $14.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Lantheus Holdings | 6.52 Bn | 5.93 Bn | 241.86 Mn | 18.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.80 Mn |
| Mar 31, 2026 | 37.99 Mn |
| Dec 31, 2025 | -65.28 Mn |
| Sep 30, 2025 | 14.61 Mn |
| Jun 30, 2025 | 25.76 Mn |
| Mar 31, 2025 | 23.58 Mn |
| Dec 31, 2024 | -85.80 Mn |
| Sep 30, 2024 | 45.03 Mn |
| Jun 30, 2024 | 22.30 Mn |
| Mar 31, 2024 | 40.20 Mn |
| Dec 31, 2023 | 37.04 Mn |
| Sep 30, 2023 | 28.00 Mn |
| Jun 30, 2023 | 29.56 Mn |
| Mar 31, 2023 | -8.30 Mn |
| Dec 31, 2022 | -57.06 Mn |
| Sep 30, 2022 | 21.78 Mn |
| Jun 30, 2022 | 18.99 Mn |
| Mar 31, 2022 | 14.94 Mn |
| Dec 31, 2021 | -792,000.00 |
| Sep 30, 2021 | -6.42 Mn |